Clinical Trials
8 trialsNCT07130786 2026-03-19
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
Brigham and Women's Hospital
Phase 2 Recruiting
NCT06442748 2026-02-13
LIBRA
Tata Memorial Centre
Phase 3 Recruiting
NCT05897658 2024-10-23
LeviTaTe Pilot
Hamilton Health Sciences Corporation
Phase 3 Not yet recruiting
NCT03436433 2023-04-13
Seizure Prophylaxis in Patients With Glioma or Brain Metastasis
Duke University
Phase 2 Terminated
NCT02334722 2021-12-15
1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
University of Florida
Phase 4 Completed
NCT00629889 2013-05-22
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
Centre Hospitalier Universitaire Vaudois
Phase 2 Completed
NCT00415376 2012-05-18
Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases
Northwestern University
Phase NA Withdrawn
NCT00571155 2009-08-20
Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery
University Hospital Tuebingen
Phase 4 Completed